Relay Therapeutics Inc. – Filings and Transcripts

NASDAQ: RLAY
Share price (9/3/26): $19.01
Market cap (9/3/26): $4.166 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Registration of securities for employees

Ownership Filter

Sb Investment Advisers (Uk) Ltd, Softbank Vision Fund (Aiv M2) L.P., SVF Pauling (Cayman) Ltd

SVF Pauling (Cayman) Ltd

News Filter

Amendment No. 1 to the Common Stock Sales Agreement

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year, Shareholder Vote Results, Financial Statements or Exhibits

Material Definitive Agreement, Financial Statements or Exhibits

Announces Initial Clinical Data Demonstrating That Zovegalisib Has Potential for Differentiated Safety and Efficacy in Patients With PIK3CA-Driven Vascular Anomalies

Reports First Quarter 2026 Financial Results and Corporate Updates

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Notice of effectiveness